Recent Updates
Recently added Catalysts
CRL Positive Sentiment

Charles River and Autolomous Partner to Transform Laboratory Execution Systems

Key Takeaway: Charles River Laboratories and Autolomous have announced the launch of Apollo Orchestrate™, a new feature within the Apollo® platform. This capability aims to digitize and connect laboratory execution systems, showcasing Charles River's ongoing commitment to modernizing laboratory workflows. The collaboration reflects a strategic move towards enhanced efficiency in drug discovery processes.

Market Sentiment Analysis

POSITIVE FACTORS

  • Launch of Apollo Orchestrate™ enhances laboratory execution.
  • Partnership with Autolomous signifies innovation in lab workflows.
  • Continued commitment to digitization by Charles River Laboratories.

Full Press Release Details

WILMINGTON, Mass. & LONDON--(BUSINESS WIRE)---- $CRL #DrugDiscover--Charles River Laboratories International, Inc. (NYSE: CRL) and Autolomous today announced the launch of Apollo Orchestrate™, a new capability within Charles River's Apollo® platform that connects and digitizes laboratory execution, built on Autolomous's autoloMATE® digital Laboratory Execution System (LES). The launch demonstrates continued progress on Charles River's strategic commitment to modernize and digitize laboratory workflows. Apollo® Orches

Frequently Asked Questions

What is Apollo Orchestrate™?

Apollo Orchestrate™ is a new capability within Charles River's Apollo® platform designed to digitize laboratory execution.

Who partnered with Charles River for this launch?

Charles River partnered with Autolomous to launch Apollo Orchestrate™.

What is the purpose of Apollo Orchestrate™?

The purpose of Apollo Orchestrate™ is to connect and modernize laboratory workflows.

What does the launch signify for Charles River?

The launch signifies Charles River's commitment to modernizing and digitizing laboratory workflows.

Last updated: Oct 6, 2026